The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza ...

Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma ...

A new group of British Members of Parliament (MPs) and peers have written to the Chancellor urging her to protect and promote ...

A new NIH clinical trial shows the Jynneos (MVA-BN) vaccine is safe for adolescents and produces an antibody response similar ...

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM) is set to grow from $11.5 billion in ...

Shares of US protein-based vaccine maker Novavax closed down 19.4% at $10.15 yesterday having dropped as much as 24%, on the ...

The US Food and Drug Administration (FDA) yesterday published the guidance for industry, “Requests for Reconsideration at the ...

Sanofi has partnered with Orano Med, a subsidiary of Orano Group, to develop radioligand therapies for rare cancers. Sanofi ...

US RNA medicines biotech Wave Life Sciences yesterday announced positive proof-of-mechanism data from the ongoing Phase ...

At the European Cell and Gene Therapy Summit 2024, confidence in the sector’s maturity and progress was evident, highlighted ...

ViiV Healthcare, the specialist HIV company majority owned by GSK (LSE: GSK), today announced the presentation of new ...

Japanese drug major Shionogi has announced new data at IDWeek 2024 from PROVE (Retrospective Cefiderocol Chart Review), the largest global real-world evidence study of Fetroja/Fetcroja (cefiderocol), ...